Moreover, previous studies suggested that HER2‐zero BC had a significantly higher prevalence of mutations in BRCA1/2 or other BC predisposition genes than HER2‐low BC.9, 12, 40, 41, 51. The gene discussed is ERBB2; the disease is breast cancer.